These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19941431)

  • 1. Evaluation and justification of clinical pharmacy services.
    Anderson SV; Schumock GT
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):539-45. PubMed ID: 19941431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy.
    Schumock GT; Meek PD; Ploetz PA; Vermeulen LC
    Pharmacotherapy; 1996; 16(6):1188-208. PubMed ID: 8947994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services.
    McGhan WF; Rowland CR; Bootman JL
    Am J Hosp Pharm; 1978 Feb; 35(2):133-40. PubMed ID: 415603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic.
    Jones RA; Lopez LM; Beall DG
    Hosp Pharm; 1991 Sep; 26(9):778-82. PubMed ID: 10114011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic outcomes and contemporary pharmacy practice.
    Reeder CE
    Am Pharm; 1993 Dec; NS33(12 Suppl):S3-6. PubMed ID: 8109541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Hospital and Community Pharmacy Services.
    Gammie T; Vogler S; Babar ZU
    Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit of a clinical services integrated with a decentralized unit dose system.
    Warrian K; Irvine-Meek J
    Can J Hosp Pharm; 1988 Jun; 41(3):109-12. PubMed ID: 10312603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
    Hakim Z; Pierson JF; Pathak DS
    Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744
    [No Abstract]   [Full Text] [Related]  

  • 11. The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services.
    Oladapo AO; Barner JC; Rascati KL
    Clin Ther; 2012 Nov; 34(11):2196-9. PubMed ID: 23149006
    [No Abstract]   [Full Text] [Related]  

  • 12. Where does high-quality research in economic evaluation come from?
    Zhang JX
    Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic effects of clinical pharmacy interventions: a literature review.
    De Rijdt T; Willems L; Simoens S
    Am J Health Syst Pharm; 2008 Jun; 65(12):1161-72. PubMed ID: 18541687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluations of clinical pharmacy services in China: a systematic review.
    Mi X; Su X; Jin Z; Zeng L; Li Z; Wang X; Zhang P; Zuo Y
    BMJ Open; 2020 Jan; 10(1):e034862. PubMed ID: 31911528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed drug-drug cost effectiveness methodology.
    Gagnon JP; Osterhaus JT
    Ann Pharmacother; 2006 Mar; 40(3):524-8. PubMed ID: 16507612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of health economic information by reimbursement authorities.
    Drummond MF
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii60-3. PubMed ID: 14585919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of therapeutic drug monitoring.
    Gardner DM; Hardy BG
    Can J Hosp Pharm; 1990 Feb; 43(1):7-12, xii. PubMed ID: 10113128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economics & the pharmacy.
    Souhrada L
    Hospitals; 1990 Oct; 64(19):52, 54, 56. PubMed ID: 2119336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature.
    Lee JT; Sanchez LA
    Am J Hosp Pharm; 1991 Dec; 48(12):2622-7. PubMed ID: 1814204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.